 | • レポートコード：MRC2205A021 • 出版社/出版日：Transparency Market Research / 2022年3月25日 • レポート形態：英文、PDF、154ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥857,660 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,301,660 (USD8,795) | ▷ お問い合わせ |
| Corporate License | ￥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Transparency Market Research社の本調査レポートは、世界のポイントオブケア（POC）診断市場について調査・分析し、序論、仮定・調査手法、エグゼクティブサマリー、市場概要、キーインサイト、プラットフォーム別（ラテラルフローアッセイ、ディップスティック、マイクロフルイディクス、分子診断、イムノアッセイ）分析、用途別分析、エンドユーザー別分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ）分析、競争状況などの項目を掲載しています。 ・序論 ・仮定・調査手法 ・エグゼクティブサマリー ・市場概要 ・キーインサイト ・世界のポイントオブケア（POC）診断市場規模：プラットフォーム別（ラテラルフローアッセイ、ディップスティック、マイクロフルイディクス、分子診断、イムノアッセイ） ・世界のポイントオブケア（POC）診断市場規模：用途別 ・世界のポイントオブケア（POC）診断市場規模：エンドユーザー別 ・世界のポイントオブケア（POC）診断市場規模：地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ） ・競争状況 |
Point-of-Care Diagnostics Market – Scope of Report
TMR’s report on the global point-of-care diagnostics market studies the past as well as current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2021 to 2028. The report provides revenue of the global point-of-care diagnostics market for the period 2017–2028, considering 2020 as the base year and 2028 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global point-of-care diagnostics market during the forecast period.
The report has been prepared after an extensive primary and secondary research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Extensive secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global point-of-care diagnostics market.
Secondary research also included Internet sources, statistical data from government agencies, websites, company presentations, sales data, and trade associations. Analysts have employed a combination of top-down and bottom-up approaches to study various phenomenon in the global point-of-care diagnostics market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global point-of-care diagnostics market. These indices serve as valuable tools for existing market players as well as for entities interested in entering the global point-of-care diagnostics market.
The report delves into the competitive landscape of the global point-of-care diagnostics market. Key players operating in the global point-of-care diagnostics market have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the global point-of-care diagnostics market that have been profiled in this report.
Key Questions Answered in Global Point-of-Care Diagnostics Market Report
What is the scope of growth of companies in the global point-of-care diagnostics market?
What will be the Y-o-Y growth of the global point-of-care diagnostics market between 2017 and 2028?
What is the influence of changing trends on the global point-of-care diagnostics market?
Will North America be the most profitable market for point-of-care diagnostics providers?
Which factors are anticipated to hamper the growth of the global point-of-care diagnostics market during the forecast period?
Which are the leading companies in the global point-of-care diagnostics market?
Research Methodology
TMR has utilized a unique research methodology to conduct comprehensive research on the growth of the global point-of-care diagnostics market and arrive at conclusions on its growth prospects. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the drawn conclusions.
Secondary methods referred to by analysts during the production of the global point-of-care diagnostics market report include statistics from company annual reports, SEC filings, company websites, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to the production of TMR’s study on the point-of-care diagnostics market as primary methods.
These primary and secondary methods have provided exclusive information during interviews, which serves as a validation from the point-of-care diagnostics market leaders. Access to an extensive internal repository and external proprietary databases enabled this report to address specific details and questions about the global point-of-care diagnostics market with accuracy. The study also uses the top-down approach to assess the revenue for each segment and the bottom-up approach to counter-validate them. This has helped in reaching TMR’s estimates on future prospects of the global point-of-care diagnostics market more reliably and accurately.
レポート目次1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Point-of-Care Diagnostics Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Point-of-Care Diagnostics Market Analysis and Forecast, 2017–2028
4.4.1. Market Revenue Projections (US$ Mn)
4.5. Porter’s Five Force Analysis
5. Key Insights
5.1. Disease Prevalence & Incidence Rate globally with key countries
5.2. Technological Advancements
5.3. Key Industry Events (mergers, acquisitions, partnerships, collaborations, etc.)
5.4. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)
6. Global Point-of-Care Diagnostics Market Analysis and Forecast, by Platform
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Platform, 2017–2028
6.3.1. Lateral Flow Assays
6.3.2. Dipsticks
6.3.3. Microfluidics
6.3.4. Molecular Diagnostics
6.3.5. Immunoassays
6.3.6. Others
6.4. Market Attractiveness Analysis, by Platform
7. Global Point-of-Care Diagnostics Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Application, 2017–2028
7.3.1. Glucose Monitoring Products
7.3.2. Cardiometabolic Monitoring Products
7.3.3. Infectious Disease Testing Products
7.3.4. Pregnancy & Fertility Testing Products
7.3.5. Urinalysis Testing Products
7.3.6. Cholesterol Testing Products
7.3.7. Hematology Testing Products
7.3.8. Drugs-of-abuse Testing Products
7.3.9. Others
7.4. Market Attractiveness Analysis, by Application
8. Global Point-of-Care Diagnostics Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by End-user, 2017–2028
8.3.1. Hospitals
8.3.2. Diagnostic Laboratories
8.3.3. Clinics/Physician Offices
8.3.4. Home Care
8.3.5. Others
8.4. Market Attractiveness Analysis, by End-user
9. Global Point-of-Care Diagnostics Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Point-of-Care Diagnostics Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Platform, 2017–2028
10.2.1. Lateral Flow Assays
10.2.2. Dipsticks
10.2.3. Microfluidics
10.2.4. Molecular Diagnostics
10.2.5. Immunoassays
10.2.6. Others
10.3. Market Value Forecast, by Application, 2017–2028
10.3.1. Glucose Monitoring Products
10.3.2. Cardiometabolic Monitoring Products
10.3.3. Infectious Disease Testing Products
10.3.4. Pregnancy & Fertility Testing Products
10.3.5. Urinalysis Testing Products
10.3.6. Cholesterol Testing Products
10.3.7. Hematology Testing Products
10.3.8. Drugs-of-abuse Testing Products
10.3.9. Others
10.4. Market Value Forecast, by End-user, 2017–2028
10.4.1. Hospitals
10.4.2. Diagnostic Laboratories
10.4.3. Clinics/Physician Offices
10.4.4. Home Care
10.4.5. Others
10.5. Market Value Forecast, by Country, 2017–2028
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Platform
10.6.2. By Application
10.6.3. By End-user
10.6.4. By Country
11. Europe Point-of-Care Diagnostics Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Platform, 2017–2028
11.2.1. Lateral Flow Assays
11.2.2. Dipsticks
11.2.3. Microfluidics
11.2.4. Molecular Diagnostics
11.2.5. Immunoassays
11.2.6. Others
11.3. Market Value Forecast, by Application, 2017–2028
11.3.1. Glucose Monitoring Products
11.3.2. Cardiometabolic Monitoring Products
11.3.3. Infectious Disease Testing Products
11.3.4. Pregnancy & Fertility Testing Products
11.3.5. Urinalysis Testing Products
11.3.6. Cholesterol Testing Products
11.3.7. Hematology Testing Products
11.3.8. Drugs-of-abuse Testing Products
11.3.9. Others
11.4. Market Value Forecast, by End-user, 2017–2028
11.4.1. Hospitals
11.4.2. Diagnostic Laboratories
11.4.3. Clinics/Physician Offices
11.4.4. Home Care
11.4.5. Others
11.5. Market Value Forecast, by Country/Sub-Region, 2017–2028
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Platform
11.6.2. By Application
11.6.3. By End-user
11.6.4. By Country/Sub-Region
12. Asia Pacific Point-of-Care Diagnostics Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Platform, 2017–2028
12.2.1. Lateral Flow Assays
12.2.2. Dipsticks
12.2.3. Microfluidics
12.2.4. Molecular Diagnostics
12.2.5. Immunoassays
12.2.6. Others
12.3. Market Value Forecast, by Application, 2017–2028
12.3.1. Glucose Monitoring Products
12.3.2. Cardiometabolic Monitoring Products
12.3.3. Infectious Disease Testing Products
12.3.4. Pregnancy & Fertility Testing Products
12.3.5. Urinalysis Testing Products
12.3.6. Cholesterol Testing Products
12.3.7. Hematology Testing Products
12.3.8. Drugs-of-abuse Testing Products
12.3.9. Others
12.4. Market Value Forecast, by End-user, 2017–2028
12.4.1. Hospitals
12.4.2. Diagnostic Laboratories
12.4.3. Clinics/Physician Offices
12.4.4. Home Care
12.4.5. Others
12.5. Market Value Forecast, by Country/Sub-Region, 2017–2028
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Platform
12.6.2. By Application
12.6.3. By End-user
12.6.4. By Country/Sub-Region
13. Latin America Point-of-Care Diagnostics Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Platform, 2017–2028
13.2.1. Lateral Flow Assays
13.2.2. Dipsticks
13.2.3. Microfluidics
13.2.4. Molecular Diagnostics
13.2.5. Immunoassays
13.2.6. Others
13.3. Market Value Forecast, by Application, 2017–2028
13.3.1. Glucose Monitoring Products
13.3.2. Cardiometabolic Monitoring Products
13.3.3. Infectious Disease Testing Products
13.3.4. Pregnancy & Fertility Testing Products
13.3.5. Urinalysis Testing Products
13.3.6. Cholesterol Testing Products
13.3.7. Hematology Testing Products
13.3.8. Drugs-of-abuse Testing Products
13.3.9. Others
13.4. Market Value Forecast, by End-user, 2017–2028
13.4.1. Hospitals
13.4.2. Diagnostic Laboratories
13.4.3. Clinics/Physician Offices
13.4.4. Home Care
13.4.5. Others
13.5. Market Value Forecast, by Country/Sub-Region, 2017–2028
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Platform
13.6.2. By Application
13.6.3. By End-user
13.6.4. By Country/Sub-Region
14. Middle East & Africa Point-of-Care Diagnostics Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Platform, 2017–2028
14.2.1. Lateral Flow Assays
14.2.2. Dipsticks
14.2.3. Microfluidics
14.2.4. Molecular Diagnostics
14.2.5. Immunoassays
14.2.6. Others
14.3. Market Value Forecast, by Application, 2017–2028
14.3.1. Glucose Monitoring Products
14.3.2. Cardiometabolic Monitoring Products
14.3.3. Infectious Disease Testing Products
14.3.4. Pregnancy & Fertility Testing Products
14.3.5. Urinalysis Testing Products
14.3.6. Cholesterol Testing Products
14.3.7. Hematology Testing Products
14.3.8. Drugs-of-abuse Testing Products
14.3.9. Others
14.4. Market Value Forecast, by End-user, 2017–2028
14.4.1. Hospitals
14.4.2. Diagnostic Laboratories
14.4.3. Clinics/Physician Offices
14.4.4. Home Care
14.4.5. Others
14.5. Market Value Forecast, by Country/Sub-Region, 2017–2028
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Platform
14.6.2. By Application
14.6.3. By End-user
14.6.4. By Country/Sub-Region
15. Competition Landscape
15.1. Market Player – Competition Matrix (by tier and size of companies)
15.2. Market Share Analysis, by Company, 2020
15.3. Company Profiles
15.3.1. F. Hoffmann-La Roche Ltd.
15.3.1.1. Overview (HQ, Employee Strength, Business Segments)
15.3.1.2. Financials
15.3.1.3. Recent Developments & Strategy
15.3.1.4. SWOT Analysis
15.3.2. bioMérieux SA
15.3.2.1. Overview (HQ, Employee Strength, Business Segments)
15.3.2.2. Financials
15.3.2.3. Recent Developments & Strategy
15.3.2.4. SWOT Analysis
15.3.3. Johnson & Johnson Services, Inc.
15.3.3.1. Overview (HQ, Employee Strength, Business Segments)
15.3.3.2. Financials
15.3.3.3. Recent Developments & Strategy
15.3.3.4. SWOT Analysis
15.3.4. Cardinal Health, Inc.
15.3.4.1. Overview (HQ, Employee Strength, Business Segments)
15.3.4.2. Financials
15.3.4.3. Recent Developments & Strategy
15.3.4.4. SWOT Analysis
15.3.5. Siemens AG
15.3.5.1. Overview (HQ, Employee Strength, Business Segments)
15.3.5.2. Financials
15.3.5.3. Recent Developments & Strategy
15.3.5.4. SWOT Analysis
15.3.6. Bio Rad Laboratories, Inc.
15.3.6.1. Overview (HQ, Employee Strength, Business Segments)
15.3.6.2. Financials
15.3.6.3. Recent Developments & Strategy
15.3.6.4. SWOT Analysis
15.3.7. BD
15.3.7.1. Overview (HQ, Employee Strength, Business Segments)
15.3.7.2. Financials
15.3.7.3. Recent Developments & Strategy
15.3.7.4. SWOT Analysis
15.3.8. Abbott
15.3.8.1. Overview (HQ, Employee Strength, Business Segments)
15.3.8.2. Financials
15.3.8.3. Recent Developments & Strategy
15.3.8.4. SWOT Analysis
15.3.9. Danaher Corporation
15.3.9.1. Overview (HQ, Employee Strength, Business Segments)
15.3.9.2. Financials
15.3.9.3. Recent Developments & Strategy
15.3.9.4. SWOT Analysis
15.3.10. Thermo Fisher Scientific, Inc.
15.3.10.1. Overview (HQ, Employee Strength, Business Segments)
15.3.10.2. Financials
15.3.10.3. Recent Developments & Strategy
15.3.10.4. SWOT Analysis